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The reaction from some quarters of the medical
profession to the extension of prescribing rights to
extended formulary nurse prescribers and pharma-
cists encompassing the whole British National Formu-
lary is likely to be seen bymany as a visceral response to
the inherent threat to powerful vested interests inwhat
has been described as the professional monolith of
medicine.1–3 Although individual nurses and pharma-
cists and their professional bodies may welcome this
move as a just reward for long and hard-fought battles
to be recognised as equal partners with the medical
profession,4 the implications of such a profound policy
change need to be examined in the cold light of the
available evidence, expected positive beneﬁts and poten-
tial negative consequences.
Despite non-medical prescribing being considered
an innovation, nurses or pharmacists have been suc-
cessfully prescribing dressings, antibiotics, contracep-
tives and a variety of other drugswith prior assessment
under patient group directions (PGDs), or ‘by proxy’
under supervision of doctors, or independently in a
variety of both hospital and community settings for
some timewith growing conﬁdence.5–7 Nurse and phar-
macist disease management clinics have been shown
to improve patient compliance and outcomes.8,9 Other
professionals such as midwives, paramedics, podiatrists,
optometrists and occupation health nurses also diag-
nose and prescribe drugs by virtue of speciﬁc pre-
scription-only medicines (POMs) exemptions under
which they operate.10 More recently, nurses and para-
medics trained as community and emergency care
practitioners prescribe from a range of primary care
drugs, such as antibiotics and analgesics, under PGDs,
often providing the point of ﬁrst contact for patients
out of hours. There are even arguments for extending
such prescribing further to address obvious anomalies,
for example nurses working as emergency care prac-
titioners are unable to administer opiates to patients
with myocardial infarction.
Will patients and professionals support the change?
In interview studies patients andmedical practitioners
appear to positively accept nurse prescribing, although
experience in practice may contradict this, and the
extent of ignorance of the change amongst the public
is not known.11–16 There are strong proponents within
the nursing and pharmacy professions, but also a
recognition that independent prescribing will increase
complexity, risk and litigation, sometimes with little
reward.17 Despite this, patients would be reassured by
Department of Health assertion of adequate training,
eﬀectiveness, cost-eﬀectiveness, and safety demon-
strated in practice.
Is there evidence for non-medical prescribing and
does it stand up to scrutiny? Notwithstanding some
evidence of adequacy of support and training there are
also indications of important gaps.18 There is early and
limited evidence that prescribing patterns of nurse
practitioners are similar to those of general prac-
titioners in certain therapeutic areas, and that pre-
scribing is eﬀective and appropriate as judged by
experts.19–21 Although lack of experience in assess-
ment and diagnosis, particularly of complex or mul-
tiple medical conditions is cited as a major drawback
of non-medical prescribing, it is diﬃcult to see why
experienced non-medical clinicians cannot learn these
skills, provided there is adequate education, assess-
ment of competence and continuing supervision and
support in both prescribing and diagnosis. Graeme-
Smith suggested that ‘prudent independent prescrib-
ing of drugs with a low beneﬁt to risk ratio requires a
thorough background in medical sciences, e.g. physi-
ology, biochemistry, molecular biology and pathol-
ogy, as well as basic and clinical pharmacology.17
Rigorous, valid and reliable evidence of competence,
arguably in these subjects as well as in diagnosis and
therapeutics for speciﬁc clinical areas, should be
welcomed by non-medical prescribers, patients and
also employers who will have responsibility for ensur-
ing that staﬀ have the ‘skills and competencies relevant
to the clinical area in which they will be prescribing’.2
Because assessment in one area of competence corre-
lates poorly with that in other areas, so-called case
speciﬁcity, assessment needs to cover all relevant areas
of practice for individual practitioners. Employers,
including general practices, may have a degree of
liability for non-negligent harm, or negligent harm if
competence is not conﬁrmed. It is also disappointing
that supervision is often provided through the
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goodwill of doctors, with little or no remuneration,
inadequate support and little recognition for this key
role.
Illich, in coining the term ‘iatrogenesis’, literally
‘physician-induced’, recognised the potential negative
impact of medicine, and in particular of drugs pre-
scribed by doctors.22 A corresponding term yet to be
coined for nurses or pharmacists will predictably be
short in coming if the fears of some commentators are
realised. There is a lack of data on safety of prescribing
and the rate of occurrence of diagnostic and treatment
errors among non-medical prescribers, whereas pre-
scribing rates of potentially hazardous or contraindicated
drug combinations for general practice prescribing have
been investigated and found to be rare.23
The diﬃculty is that the potential harms, in parallel
with medical prescribing, are ubiquitous, and include
errors frommisdiagnosis, interactionswith prescribed
and non-prescribedmedications or foods, inadvertent
or inappropriate prescribing and inﬂuence from
pharmaceutical companies.24–26 Systems formonitor-
ing nurse prescribing and reporting errors are yet to be
developed to the extent that routine information is
widely available. In the current climate there may be
reluctance to report errors or perverse disincentives to
reporting, whether by doctors or other professionals,
since reporting will inevitably involve costs, ﬁnancial
or time, hostility, suspension or sickness absence
of employed staﬀ, loss of morale, and disruption to
working relationships.
The classic prerequisites for diﬀusion of extended
prescribing are in place.27 Can the quality of prescrib-
ing in primary care bemaintained and negative conse-
quences prevented or contained? The answer should
be a qualiﬁed yes; but clear evidence of competence in
diagnosis and treatment and robust systems of pre-
scription monitoring, patient safety and clinical govern-
ance are needed to reassure patients, professionals and
employers to positively support our colleagues and
successfully implement non-medical prescribing.
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